SCHEMBL9813652

SCHEMBL9813652

Cc1cccc(NC(=O)/C=C2\SCC(=O)N2C)c1C

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.66
▸ TDP1 Q9NUW8 1/20 0.66
▸ PSMD14 O00487 1/20 0.57
▸ TP53 P04637 2/20 0.44
▸ HTT P42858 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ THRB P10828 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9813655 1.00 ALDH1A1 (0.66) ALDH1A1TDP1PSMD14TP53HTT
SCHEMBL9813569 0.86 PSMD14 (0.61) ALDH1A1TDP1PSMD14TP53HTT
SCHEMBL9813566 0.86 PSMD14 (0.61) ALDH1A1TDP1PSMD14TP53HTT
SCHEMBL9813546 0.81 ALDH1A1 (0.71) ALDH1A1TDP1PSMD14NPC1RAB9A
SCHEMBL9813545 0.81 ALDH1A1 (0.71) ALDH1A1TDP1PSMD14NPC1RAB9A
Ralitoline SCHEMBL635346 0.81 PSMD14 (0.55) ALDH1A1TDP1PSMD14GAA
Ralitoline SCHEMBL9813595 0.81 PSMD14 (0.55) ALDH1A1TDP1PSMD14GAA
SCHEMBL10853625 0.80 PSMD14 (0.60) ALDH1A1TDP1PSMD14TP53HTT
SCHEMBL9813540 0.80 PSMD14 (0.60) ALDH1A1TDP1PSMD14TP53HTT
SCHEMBL9813617 0.79 ALDH1A1 (0.71) ALDH1A1TDP1PSMD14LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP disclosed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US disclosed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP disclosed
Send feedback